Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JI-101 |
Trade Name | |
Synonyms | CGI-1842 |
Drug Descriptions |
JI-101 inhibits KDR (VEGFR2), PDGFR-beta (PDGFRB), and EphB4, resulting in anti-tumor activity (PMID: 26365907, PMID: 32336043). |
DrugClasses | EPHB4 Inhibitor 6 PDGFR-beta Inhibitor 14 VEGFR2 Inhibitor 37 |
CAS Registry Number | 900573-88-8 |
NCIT ID | C82413 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Everolimus + JI-101 | Everolimus JI-101 | 0 | 0 |
JI-101 | JI-101 | 0 | 0 |